Dishman Carbogen Amcis announced that the USFDA inspection planned between 04 March 2024 and 08 March 2024 at the company`s facility in Bavla, Ahmedabad, was completed on 07 March 2024. No any serious issue was raised during the course for the entire inspection.With this, the company`s facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the US FDAPowered by Capital Market - Live News

Net loss of Dishman Carbogen Amcis reported to Rs 59.63 crore in the quarter ended December 2023 as against net profit of Rs 46.96 crore during the previous quarter ended December 2022. Sales rose 1.77% to Rs 651.09 crore in the quarter ended December 2023 as against Rs 639.79 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales651.09639.79 2 OPM %6.3117.80 - PBDT14.0898.46 -86 PBT-66.2948.13 PL NP-59.6346.96 PL Powered by Capital Market - Live News

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net Loss of Dishman Carbogen Amcis reported to Rs 40.90 crore in the quarter ended September 2023 as against net loss of Rs 10.05 crore during the previous quarter ended September 2022. Sales declined 4.46% to Rs 586.59 crore in the quarter ended September 2023 as against Rs 613.96 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales586.59613.96 -4 OPM %10.3712.80 - PBDT41.8367.28 -38 PBT-33.21-12.29 -170 NP-40.90-10.05 -307 Powered by Capital Market - Live News

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News